Ovarian drilling in treatment of infertility with dystrophic ovaries

##plugins.themes.academic_pro.article.sidebar##

Published Mar 5, 2012
Download
pdf
Vol. 90 No. 2 (2012): Issue Feb 2012

##plugins.themes.academic_pro.article.main##

Mourali Mechaal
Kawali Abdelkarim
Fitouhi Lobna
Bekri Sondes
Hmila Faouzia
Binous Naoufel
Ben Zineb Nabil
El Fekih Chiraz

Abstract

Background: Dystrophic ovaries represent the main cause of female infertility in Tunisia
Aim: To assess the contribution of ovarian drilling in the treatment of infertility in patients with ovarian dystrophy.
Methods: A retrospective study of 23 patients with dystrophic ovaries that have benefited through their subfertility of laparoscopic ovarian drilling, in the gynecology-obstetrics hospital Mahmoud EL Matri, Ariana, Tunisia. Our study spans a period of 3 years from January 2004 to December 2006.
Results: Among the 23 patients who underwent drilling for clomiphene citrate resistance, 9 have been pregnant. The average age of patients having had a pregnancy after ovarian drilling was 29.6 years, the average delay was 7.1mois. Regarding prognostic factors, only infertility’s duration lower than 3 years was predictive of a good result.
Conclusion: Ovarian drilling is an interesting alternative to induction by FSH for patients with dystrophic ovaries.

Keywords:

Infertility - ovarian drilling - polycystic ovary syndrome (PCOS) - ovarian dystrophy

##plugins.themes.academic_pro.article.details##

References

  1. Pugeat M. Les traitements hors FIV du SOPK : l'amaigrissement et les agents insulino-sensibilisants. Gynecol Obstet Biol Reprod 2003; 32: 25-29.
  2. Fernandez H, Gervaise A, Alby JD, Kadoch J. La place du drilling ovarien dans la prise en charge du syndrome des ovaires polykystiques. Gynécol Obstét Fertil 2003; 31:207-13.
  3. Belaisch Allart JP, Nahmanovici C. L'ovaire de l'insulinorésistance. Gynécol Obstét Fertil 2001; 29 :680-91.
  4. Diedrich K, Diedrich E, Santos E, et al. Suppression of the endogenous LH -Surge by the GnRH antagonist Cetrorelix during ovarien stimulation. Hum Reprod 1994;9 :788-9.
  5. Zawadaski JK, Dunaif A. Diagnosis criteria for polycystic ovary syndrome: Towards a rational approach. In Polycystic ovary syndrome. Boston: BlachWell Scientific 1992; 377- 84.
  6. Rotterdam ESHRE / ASRM-Sponsored PCSO. Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Hum Reprod 2004; 19: 41-7.
  7. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum reprod Update 2003 ; 9: 505-11.
  8. Fernandez H. Traité de Gynécologie. Médecine-Sciences Flammarion 2005.
  9. Asuncion M, Calmo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasion women from spain. J Clin Endocrinol Metab 2000 ; 85 : 2434-8.
  10. Strauss JF. Épidémiologie et génétique du syndrome des ovaires polykystiques : les données récentes. J Gynecol Obstet Biol Reprod 2003 ; 32 : 2S11-2S16.
  11. Bouchard Ph, Physiopathologie et diagnostic du syndrome des ovaires polykystiques. J Gynecol Obstet Biol Reprod 2003; 2: 2S05-2S10.
  12. Ibanez L, Zegher F, Potau N. Anovulation after precocious pubarche: early maekers and time course in adolescence. J Clin Endocrinol Metab 1999; 84:2691-5.
  13. Dunaif A, Segal KR, Futterweit W, Dobrjanssky A. Profound peripheral insulinresistance, independent obesity , in polycystic ovary syndrome. Diabetes 1989; 38 : 1165-74.
  14. Laboureau-SoaresBarbosas S, Rodien P, Rachédi F, Rohmer V. Les nouveaux traitements médicaux du syndrome des ovaires polykystiques. J Gynecol Obstet Biol Reprod 2003; 32: 685-91.
  15. Macgregor AH, Johnson JE, Bunde CA. Further experience with clomiphene citrate. Fertil Steril 1968; 19: 616-22.
  16. Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 1985;12: 605-632.
  17. Garcia J, Jones GS, Wentz AC. The use of clomiphene citrate. Fertil Steril 1977; 28: 707-17.
  18. Barbieri RL. Metformin for the treatment of polycystic ovary syndrome. Obstet Gynecol 2003; 101:785-93.
  19. Palomba S, Orio F, NardoL G, Falbo A, et al. Metformine administration versus laparoscopic ovarien diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomised double blind placebo—contolled trial. J Clin Endocrinol Metab 2004; 89:4801-9.
  20. Genazzani AD, Battaglia C, Malavasi B et al. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarien function in non-obese patients with PCOS. Fertil Steril 2004; 81: 114-9.
  21. Guzik DS. Polycystic ovary syndrome. Obstet Gynecol 2004;103:181-93.
  22. Gervaise A, Fernandez H. Le drilling ovarien dans le traitement des ovaries polykystiques. Gynecol Obstet Fertil 2005; 33:713- 17.
  23. Gomel V. Pour le traitement chirurgical du syndrome des ovaires poly kystiques. J Gynecol Ostet Biol Reprod 2003; 32: 2S46- 2S49.
  24. Gjonnaess H. Polycystic ovary syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril 1984; 41: 20-25.
  25. Campo S. Ovulatory cycles, pregnancy outcome and complications after surgical treatment of polycystic ovary syndrome. Obstet Gynecol Surv 1998; 53:297-308.
  26. Li TC, Saravelos H, Chow MS, Chisabingo R, Cooke ID. Factors affecting the outcome of laparoscopieovarien drilling for polycystic ovarien disease in women with anovulatory infertility. Br J Obstet Gynecol 1998; 105:338-44
  27. Merchant RN. Treatment of polycystic ovary disease with laparoscopic low-watt bipolar electrocoagulation of the ovaries. J Am Assoc Gynecol Laparosc 1996.3: 5038.
  28. Fernandez H. Une alternative pour traiter l'infertilité : le drilling ovarien .Gynécol obstét Fertil 2009 ; 37 : 17-18
  29. Kriplani A, Manchanda R, Agarwal N, Nayar B. Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome. J Am Assoc Gynecol Laparosc 2001;8:511-8.
  30. Takeuchi S, Futamura N, Takubo S, Noda N, Minoura H, Toyoda N. Polycystic ovary syndrome treated with laparoscopic ovarian drilling with a harmonic scalpel. A prospective, randomized study. J Reprod Med 2002;47:816-20.
  31. Amer SA, Banu Z, Li TC, Cooke ID. Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes. Hum Reprod 2002; 17: 2851-7.
  32. Gjonnaess H. Ovarian electrocautery in the treatment of women with polycystic ovary syndrome (PCOS). Factors affecting the results. Acta Obstet Gynecol Scand 1994; 73: 407- 12.
  33. Aakvaag A, Gjonnaess H. Hormonal response to electrocautery of the ovary in patients with polycystic ovary disease. Br J Obstet Gynaecol 1985; 92: 1258 -64.
  34. Gjonnaess H, Norman N. Endocrine effects of the ovarian electrocautery in patients with polycystic ovary disease. Br J Obstet Gynecol 1987; 94 : 779 -83.
  35. Taskin O, Yalcinoglu AI, Kafkasli A, Burak F, Ozekici U. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease. Fertil Steril 1996; 65 : 1115 -18.
  36. Thulandi T, Tooks S. Surgical management of polycystic ovarian syndrome. Bailliers Clin Obstet Gynecol 1998;12 :541-53.
  37. Amer SAKS, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarien drilling in Women with polycystic ovarian syndrome: predictors of success. Hum Reprod 2004; 19:1719-24.
  38. F Mercorio, A Mercorio. Evaluation of ovarien adhesion formation after ovarian laparoscopic drilling by second - look mini laparoscopy. Fertil Steril 2008;89:1229-33.
  39. M.Kandil, M. Salim. Hormonal ad sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome. Br J Obstet Gynecol 2005; 112: 1427-30.
  40. Amer SA, Li TC, Cooke ID. Repeated laparoscopic ovarian diathermy is effective in women with anovulatory infertility due to polycystic ovary syndrome. Fertil Steril 2003;79:1211-5.
  41. Stegmann BJ, Craig HR, Bay RC, Coonrod DV, Brady MJ, Garbaciak JA Jr. Characteristics predictive of response to ovarian diathermy in women with polycystic ovarian syndrome. Am J Obstet Gynecol 2003;188:1171- 3.
  42. Gadir AA, Mowafi RS, Alnaser HM. Ovarien electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatement of patients with polycystic ovarien disease. Clin endocr 1990; 33: 585.
  43. Gjonnaess H. Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome. Fertil Steril 1998;69:697-701.
  44. Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2007;(3):CD001122.
  45. Farquhar CM. An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrateresistant polycystic ovarian syndrome. Curr Opin Obstet Gynecol 2005;17:347-53.
  46. Farquhar CM, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L. A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril 2002;78:404-11.
  47. Capelo FO, Kumar A, Steinkampf MP, Azziz R. Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate. Fertil Steril 2003;80:1450-3.